AbbVie received Food and Drug Administration approval of Emblaveo, an intravenous antibiotic, for treatment of adults with complicated intra-abdominal infections with limited or no treatment options.

Emblaveo is a fixed-dose IV treatment that combines aztreonam, a monobactam antibiotic, and avibactam, a β-lactamase inhibitor.

Additionally, connectivity-enabled central dashboards in infusion therapy, such as OSAA Innovation’s iV-VIEW dashboard, use the data transferred from every connected device and can identify the ...

Results: Paracetamol was effective in relieving pain due to OA (ES = 0.21, 95% confidence interval (CI) 0.02 to 0.41). Non-steroidal anti-inflammatory drugs (NSAIDs) were better than paracetamol for ...

DMTs are available in three different forms—injections, oral therapies, and IV infusions. DMTs are drugs to improve the long-term outlook of the condition. They reduce the number and severity of MS ...

Prince Karim al-Husseini, who was the Aga Khan IV, died in Lisbon on Tuesday (February 4). He was 88. Considered to be a direct descendant of the Prophet Muhammad through his daughter Fatima and ...

Mission Statement: Evidence-based Complementary and Alternative Medicine (eCAM) is an international, peer-reviewed journal that seeks to understand the sources and to encourage rigorous research ...